These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8228483)

  • 41. Platelet transfusions to HLA-immunized recipients: how to be or not to be matched.
    Rubinstein P
    Transfusion; 2010 Nov; 50(11):2292-4. PubMed ID: 21182628
    [No Abstract]   [Full Text] [Related]  

  • 42. [Application of platelet transfusion and their problems].
    Ryo R; Hashimoto M; Takada S; Goto M; Yamaguchi N
    Nihon Naika Gakkai Zasshi; 1993 Jul; 82(7):1047-52. PubMed ID: 8228483
    [No Abstract]   [Full Text] [Related]  

  • 43. [Transfusion of platelet concentrates].
    Rieux C; Lee K; Lavaud A; Bierling P
    Ann Med Interne (Paris); 1999 Dec; 150(8):631-41. PubMed ID: 10686645
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Guidelines for substitution therapy with thrombocytes].
    Bux J; Mueller-Eckhardt C
    Dtsch Med Wochenschr; 1993 Sep; 118(38):1367-70. PubMed ID: 8404478
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical aspects of platelet transfusion].
    Julia A; Massuet L; Pujol M; Martín Vega C
    Sangre (Barc); 1985; 30(4-B):548-56. PubMed ID: 3909466
    [No Abstract]   [Full Text] [Related]  

  • 46. The use of leukocyte-reduced blood components.
    Miller JP; Mintz PD
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):69-90. PubMed ID: 7737945
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Platelet transfusion refractoriness.
    Hod E; Schwartz J
    Br J Haematol; 2008 Jul; 142(3):348-60. PubMed ID: 18510692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Post-transfusion graft-versus-host disease].
    Takahashi K
    Rinsho Ketsueki; 1992 May; 33(5):582-6. PubMed ID: 1630009
    [No Abstract]   [Full Text] [Related]  

  • 49. [Adverse effects and infections caused by platelet concentrate].
    Tadokoro K
    Rinsho Ketsueki; 2000 Jun; 41(6):468-71. PubMed ID: 10921343
    [No Abstract]   [Full Text] [Related]  

  • 50. [Post-transfusion GVHD].
    Tadokoro K; Juji T
    Nihon Rinsho; 2002 Jan; 60 Suppl 1():724-31. PubMed ID: 11838191
    [No Abstract]   [Full Text] [Related]  

  • 51. [Refractoriness to platelet transfusion].
    Tsurumi H; Hara T; Moriwaki H
    Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):332-4. PubMed ID: 9833505
    [No Abstract]   [Full Text] [Related]  

  • 52. [Transfusion-refractory thrombocytopenia during chemotherapy: pathogenesis, frequency and treatment].
    Helleberg C; Taaning EB; Johnsen HE
    Ugeskr Laeger; 1995 Sep; 157(37):5082-6. PubMed ID: 7502374
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transfusion-associated graft-versus-host disease.
    Anderson KC; Weinstein HJ
    N Engl J Med; 1990 Aug; 323(5):315-21. PubMed ID: 2248640
    [No Abstract]   [Full Text] [Related]  

  • 54. Donor selection in platelet transfusion therapy of alloimmunized thrombocytopenic patients.
    Duqesnoy RJ
    Prog Clin Biol Res; 1978; 28():229-43. PubMed ID: 88057
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.